Sanofi with We Are ILL, Inc. Rings the Opening Bell
About This EventSanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in Times Square. A patient advocacy organization, We Are ILL redefines what “sick” looks like by making the ...
Is Sanofi (SNY)the Best Gene-Editing Stock to Buy?
We recently published a list of 8 Best Gene-Editing Stocks to Buy. In this article, we are going to take a look at where ...
The Pharma Letter19h
Nurix expands licensing deal with Sanofi
US clinical-stage biotech Nurix Therapeutics (Nasdaq: NRIX) announced that Sanofi (Euronext: SAN) has exclusively licensed an ...
ETF Daily News2d
Q1 Earnings Forecast for Sanofi Issued By Leerink Partnrs
View Our Latest Stock Report on Sanofi Sanofi Stock Down 2.0 % Shares of NASDAQ:SNY opened at $54.34 on Tuesday. The company has a 50 day moving average price of $55.28 and a two-hundred day ...
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
The undisclosed target is a central regulator of inflammation that is distinct from the previously disclosed STAT6 programNurix DEL-AI drug ...
Analysts Set Sanofi (NASDAQ:SNY) PT at $60.00
Sanofi (NASDAQ:SNY – Get Free Report) has been assigned an average recommendation of “Buy” from the five analysts that are currently covering the stock, Marketbeat Ratings reports. Two research ...
FDA Approves Sanofi's Hemophilia Drug
The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin ...
Regeneron (NASDAQ:REGN) and Sanofi Get Japan Green Light for Smokers’ Lung Disease Treatment
Biotech company Regeneron (REGN) and French pharmaceutical giant Sanofi (SNY) today announced that Japan has granted ...
Sanofi gets priority review for its multiple sclerosis treatment by FDA
Sanofi (NASDAQ:SNY) said on Tuesday that the US FDA has granted priority review to the regulatory submission of tolebrutinib ...
Nasdaq2d
Sanofi with We Are ILL, Inc. Rings the Nasdaq Stock Market Opening Bell
Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Sanofi (Nasdaq: SNY) with We Are ILL, Inc., visits the Nasdaq MarketSite in ...
Yahoo Finance3d
FDA Approves Sanofi's Hemophilia Drug
The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin-lowering (AT) therapy for routine prophylaxis to prevent or reduce ...